Current situation and thoughts on radiofrequency ablation in the treatment of thyroid cancers

VernacularTitle: 射频消融治疗甲状腺癌的现状与思考
Author: Hao ZHANG ¹ ; Wenwu DONG
Author Information

1. Department of Thyroid Surgery, the First Hospital, China Medical University, Shenyang 110001, China
Publication Type:Journal Article
Keywords: Thyroid neoplasms; Ablation techniques; Surgical procedures, operative
From: Chinese Journal of Surgery 2017;55(8):574-578
CountryChina
Language:Chinese
Abstract: Radiofrequency ablation (RFA) was originally used primarily for the treatment of regional metastatic lymph nodes from recurrent thyroid cancers in the field of thyroid surgery. In recent years it is gradually used to treat a part of benign thyroid nodules. However, the domestic issues resulting from indiscriminately enlarged RFA indication and lack of standardization of therapy become more and more prominent, including initial treatment of operable thyroid cancers by RFA, which is against by the current consensus about RFA for patients with thyroid nodules and management guidelines for patients with thyroid cancers. Therefore, RFA should be avoided for initial treatment of operable thyroid cancers before the introduction of guidelines based on evidence-based medicine.